Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Talk2 Technologies is a digital health company specializing in the development of voice-based artificial intelligence to monitor and diagnose health conditions. By analyzing vocal biomarkers, the company's platform can detect subtle changes in speech patterns associated with mental health disorders, respiratory issues, and neurological conditions. Their technology is designed to provide non-invasive, objective, and continuous monitoring for patients and clinical trial participants. Talk2 Technologies aims to integrate these insights into healthcare workflows to improve early detection and personalized treatment. The company focuses on "acoustic epidemiology" to understand how vocal changes correlate with disease progression and treatment response.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Talk2 Technologies.